The results of EMPATROPISM-FE, a post hoc analysis of the EMPA-TROPISM trial performed by Angermann et al., suggest that the beneficial effects of empagliflozin treatment in heart failure populations may be related to changes in iron metabolism.
- Christiane E. Angermann
- Carlos G. Santos-Gallego
- Juan J. Badimon